Financials
- Market Capitalization 400.55 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
3.68
Fiyat/satışlar oranı
35.88
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3050 | LRMR Larimar Therapeutics, Inc. - Common Stock | 4.01 USD | -0.99% | -5.20% | +4.97% | +9.56% | 416.57 M USD | ||
| 3069 | GALT Galectin Therapeutics Inc. - Common Stock | 4.02 USD | -2.90% | +9.24% | +23.31% | -6.07% | 405.42 M USD | ||
| 3079 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.86 USD | -2.61% | -0.41% | +10.96% | +1.89% | 398.74 M USD | ||
| 3085 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.60 USD | -1.45% | +1.19% | +4.78% | +56.32% | 396.11 M USD |